FDA approves new antibiotic to treat UTIs in females
Global News
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in women and adolescent girls.
The U.S. Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker has been expecting this year.
The antibiotic, branded as Blujepa, is approved for women aged 12 years and older to treat uncomplicated UTIs, which are bacterial infections affecting the lower urinary tract in otherwise healthy individuals.
GSK plans to launch the drug in the U.S. in the second half of the year, and did not disclose details on pricing.
GSK is banking on new drugs in its infectious diseases portfolio, including its recently launched respiratory syncytial virus vaccine, to make up for lost revenues from its best-selling medicines and looming patent losses for its HIV treatments.
Over half of all women will experience uncomplicated UTIs in their lifetime, and around 30 per cent will suffer at least one recurrent episode, according to GSK.
The drug chemically known as gepotidacin is designed to target the most common UTI-causing bacteria such as E. coli, the company said.
The drug acts on a different part of the bacteria compared to most other antibiotics, making it effective against organisms resistant to current treatments, according to GSK.
The bacteria is also less likely to develop resistance to the drug, as it would need to mutate in both the enzymes that gepotidacin targets, according to GSK.
Run 3 Space | Play Space Running Game
Traffic Jam 3D | Online Racing Game
Duck Hunt | Play Old Classic Game
Bird flu has been detected in a sheep in northern England, the first known case of its kind in the world, Britain's government said.
23andMe on Sunday filed for bankruptcy in the United States after struggling with the fallout of a data breach and weak demand for its ancestry testing kits.
A new study suggests AI can predict premature death among people who have inflammatory bowel disease, also known as Crohn's and colitis.
Spring is about transformation, a season often marked by its dynamic sights, smells, sounds and tastes. As humans change the climate, our experience of the season is changing, too.
The report from Citizen Lab at the University of Toronto said researchers traced the IP address of a Paragon Solutions client to the OPP's general headquarters.
As bird flu continues to sweep through poultry farms, United States Health Secretary Robert F. Kennedy Jr. is proposing a different approach: let the virus spread.
A New Brunswick woman says she has no choice but to turn to the private sector to get refills for her medication -- and it's a costly process.
Avalanche Canada issued the warning late Thursday, which covers Banff, Yoho, Kootenay, and Jasper National Parks, and Kananaskis Country.
Google will buy cybersecurity firm Wiz for US$32 billion to boost the tech giant’s in-house cloud computing amid burgeoning artificial intelligence growth.
The Liberals introduced draft regulations back in November that require producers to cut emissions by about one-third over the next eight years.
An advocate for patients of New Brunswick's alleged mystery neurological disease says the province's health minister has not been honest with her.
As the avian flu continues to spread, some people may be wondering if it is still safe to use their bird feeder. Here's what the experts say.
Students at Dinsmore Composite School, an hour and a half southwest of Saskatoon, have built their own hydroponic garden tower to grow produce year-round.